← Find more feeds

chugai-pharm.co.jp

Chugai Pharmaceutical: News Releases

Get the latest updates from Chugai Pharmaceutical: News Releases directly as they happen.

Follow now 168 followers

Latest posts

Last updated 3 days ago

Roche’s Announcement Regarding Trontinemab (Presentation of Latest Data in Alzheimer’s Disease at AAIC)

3 days ago

Read full

Chugai Announces 2025 2nd Quarter Results

7 days ago

Read full

Chugai to Construct a New Laboratory Building “UKX” to Strengthen Manufacturing Process Development Capabilities and Advance Environmental Initiatives toward TOP I 2030

7 days ago

Read full

F. Hoffmann-La Roche Announces Half Year Results 2025

7 days ago

Read full

Chugai and Gero Enter into Joint Research and License Agreement to Develop Novel Therapies for Age-Related Diseases

24 days ago

Read full

Chugai Files for Additional Tumor-Agnostic Indication of Alecensa for ALK Fusion / Rearrangement Gene-Positive Solid Tumors Including Pediatric Patients

about 1 month ago

Read full

Eli Lilly’s Announcement Regarding Oral GLP-1 Orforglipron (Results of Phase III ACHIEVE-1 for Type 2 Diabetes Published in The New England Journal of Medicine)

about 1 month ago

Read full

Phase I/II Study in Hemophilia A Suggests NXT007 May Have the Potential to Provide Hemostatic Normalization

about 1 month ago

Read full

Roche Announces Global Phase III SUNMO Study Data for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (Combination Therapy with Lunsumio and Polivy)

about 1 month ago

Read full

Roche Announces New Safety Information of Elevidys for Non-Ambulatory Duchenne Muscular Dystrophy

about 1 month ago

Read full

Galderma’s Announcement Regarding NEMLUVIO (New Long Term Data Presentation in Atopic Dermatitis)

about 2 months ago

Read full

Verastem Oncology’s Announcement Regarding AVMAPKI (Positive Updated Results from RAMP 205 Evaluating Avutometinib Plus Defactinib in Combination with Standard-of-Care Chemotherapy in Frontline Metastatic Pancreatic Ductal Adenocarcinoma)

2 months ago

Read full

Or log in

Everything you care about in one place

Chugai Pharmaceutical: News Releases

Latest posts

Roche’s Announcement Regarding Trontinemab (Presentation of Latest Data in Alzheimer’s Disease at AAIC)

Chugai Announces 2025 2nd Quarter Results

Chugai to Construct a New Laboratory Building “UKX” to Strengthen Manufacturing Process Development Capabilities and Advance Environmental Initiatives toward TOP I 2030

F. Hoffmann-La Roche Announces Half Year Results 2025

Chugai and Gero Enter into Joint Research and License Agreement to Develop Novel Therapies for Age-Related Diseases

Chugai Files for Additional Tumor-Agnostic Indication of Alecensa for ALK Fusion / Rearrangement Gene-Positive Solid Tumors Including Pediatric Patients

Eli Lilly’s Announcement Regarding Oral GLP-1 Orforglipron (Results of Phase III ACHIEVE-1 for Type 2 Diabetes Published in The New England Journal of Medicine)

Phase I/II Study in Hemophilia A Suggests NXT007 May Have the Potential to Provide Hemostatic Normalization

Roche Announces Global Phase III SUNMO Study Data for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (Combination Therapy with Lunsumio and Polivy)

Roche Announces New Safety Information of Elevidys for Non-Ambulatory Duchenne Muscular Dystrophy

Galderma’s Announcement Regarding NEMLUVIO (New Long Term Data Presentation in Atopic Dermatitis)

Verastem Oncology’s Announcement Regarding AVMAPKI (Positive Updated Results from RAMP 205 Evaluating Avutometinib Plus Defactinib in Combination with Standard-of-Care Chemotherapy in Frontline Metastatic Pancreatic Ductal Adenocarcinoma)

Try Feeder for free